AAAAAA

   
Results: 1-18 |
Results: 18
Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop
Authors: De Gruttola, VG Clax, P DeMets, DL Downing, GJ Ellenberg, SS Friedman, L Gail, MH Prentice, R Wittes, J Zeger, SL
Citation: Vg. De Gruttola et al., Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop, CONTR CL TR, 22(5), 2001, pp. 485-502
Untitled - Reply
Authors: Gong, JJ Pinheiro, JC DeMets, DL
Citation: Jj. Gong et al., Untitled - Reply, CONTR CL TR, 22(2), 2001, pp. 192-194
Effect of carvedilol on survival in severe chronic heart failure.
Authors: Packer, M Coats, AJS Fowler, MB Katus, HA Krum, H Mohacsi, P Rouleau, JL Tendera, M Castaigne, A Roecker, EB Schultz, MK DeMets, DL
Citation: M. Packer et al., Effect of carvedilol on survival in severe chronic heart failure., N ENG J MED, 344(22), 2001, pp. 1651-1658
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
Authors: Atkinson, AJ Colburn, WA DeGruttola, VG DeMets, DL Downing, GJ Hoth, DF Oates, JA Peck, CC Schooley, RT Spilker, BA Woodcock, J Zeger, SL
Citation: Aj. Atkinson et al., Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework, CLIN PHARM, 69(3), 2001, pp. 89-95
Statistical issues relating to international differences in clinical trials
Authors: O'Shea, JC DeMets, DL
Citation: Jc. O'Shea et Dl. Demets, Statistical issues relating to international differences in clinical trials, AM HEART J, 142(1), 2001, pp. 21-28
The Data and Safety Monitoring Committee: Some final thoughts
Authors: DeMets, DL Yusuf, S
Citation: Dl. Demets et S. Yusuf, The Data and Safety Monitoring Committee: Some final thoughts, AM HEART J, 141(4), 2001, pp. 548-549
An overview of group sequential methods in longitudinal clinical trials
Authors: Spiessens, B Lesaffre, E Verbeke, G Kim, K DeMets, DL
Citation: B. Spiessens et al., An overview of group sequential methods in longitudinal clinical trials, STAT ME M R, 9(5), 2000, pp. 497-515
Estimating significance level and power comparisons for testing multiple endpoints in clinical trials
Authors: Gong, JJ Pinheiro, JC DeMets, DL
Citation: Jj. Gong et al., Estimating significance level and power comparisons for testing multiple endpoints in clinical trials, CONTR CL TR, 21(4), 2000, pp. 313-329
Computations for group sequential boundaries using the Lan-DeMets spendingfunction method
Authors: Reboussin, DM DeMets, DL Kim, K Lan, KKG
Citation: Dm. Reboussin et al., Computations for group sequential boundaries using the Lan-DeMets spendingfunction method, CONTR CL TR, 21(3), 2000, pp. 190-207
Relationships between Data Monitoring Committees
Authors: DeMets, DL
Citation: Dl. Demets, Relationships between Data Monitoring Committees, CONTR CL TR, 21(1), 2000, pp. 54-55
The role of surrogate outcome measures in evaluating medical devices
Authors: DeMets, DL
Citation: Dl. Demets, The role of surrogate outcome measures in evaluating medical devices, SURGERY, 128(3), 2000, pp. 379-385
Design of Phase II trials in congestive heart failure
Authors: DeMets, DL
Citation: Dl. Demets, Design of Phase II trials in congestive heart failure, AM HEART J, 139(4), 2000, pp. S207-S210
Statistics and ethics in medical research
Authors: DeMets, DL
Citation: Dl. Demets, Statistics and ethics in medical research, SCI ENG ETH, 5(1), 1999, pp. 97-117
On the bias of estimation of a Brownian motion drift following group sequential tests
Authors: Li, ZQ DeMets, DL
Citation: Zq. Li et Dl. Demets, On the bias of estimation of a Brownian motion drift following group sequential tests, STAT SINICA, 9(4), 1999, pp. 923-937
Bias correction in group sequential analysis with correlated data
Authors: Qu, RP DeMets, DL
Citation: Rp. Qu et Dl. Demets, Bias correction in group sequential analysis with correlated data, STAT SINICA, 9(4), 1999, pp. 939-952
The agonising negative trend in monitoring of clinical trials
Authors: DeMets, DL Pocock, SJ Julian, DG
Citation: Dl. Demets et al., The agonising negative trend in monitoring of clinical trials, LANCET, 354(9194), 1999, pp. 1983-1988
Effect of metoprolol CR XL in chronic heart failure: Metoprolol CR XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
Authors: Hjalmarson, A Goldstein, S Fagerberg, B Wedel, H Waagstein, F Kjekshus, J Wikstrand, J Hassle, A Westergren, G Hassle, A Thimell, M El Allaf, D Vitovec, J Aldershvile, J Halinen, M Dietz, R Neuhaus, KL Janosi, A Thorgeirsson, G Dunselman, P Gullestad, L Kuch, J Herlitz, J Rickenbacher, P Ball, S Gottlieb, S Deedwania, P Vandenhoven, G Novakova, I Danker, S Lundstrom, M Meyer-Sabellek, W Balla, I Sveinsdottir, M Dorhout, B Hildebrandt, A Szczurko, I Larsson, C Bucher, E Scott, E Dwyer, D Julian, DG DeMets, DL Chatterjee, K Feyzi, J Lehto, S Karpati, P Motz, W Samuelsson, O Viersma, JW Andersson, B Berthe, C Boutefeu, JM Boxho, G Decroly, P Derbaudrenghien, JP El Allaf, D Pirlet, J Henry, P Heyndrickx, G Missault, L Nannan, M Timmermans, P Vachiery, JL Van Mieghem, W Vandenbossche, JL Dvorak, K Herold, M Hradec, J Kana, A Petr, P Rybka, J Smid, J Svitil, P Toman, J Vitovec, J Agner, E Aldershvile, J Amtorp, O Egstrup, K Eliasen, P Gotzsche, CO Hildebrandt, P Johannesen, A Kaiser-Nielsen, P Nielsen, H Nielsen, PE Pedersen, F Nielsen, JR Skagen, K Halinen, M Honkanen, T Hussi, E Juvonen, J Jaaskelainen, H Rinne, J Salonen, T Andresen, D Berwing, H Dietz, R Forster, A Hauf, GF Krosse, B Luderitz, B von Olshausen, KE Schmailzl, KJG Schwimmbeck, PL Sigmund, M Voller, H Czuriga, I Hetey, M Janosi, A Katona, A Lengyel, M Nyaradi, A Rednik, A Sandori, K Szabo, P Tarjan, J Tenczer, J Timar, S Valyi, P Veress, G Zamolyi, K Oze, B Thorgeirsson, G Thorgeirsson, G Bernink, PJLM Bredero, AC Breedveld, RW Breuls, PNWM Bucx, JJJ Cornel, JH De Milliano, PAR Dunselman, PHJM Hamer, BJB Holwerda, NL Hoogsteen, J Hoorntje, JCA Kragten, JA Liem, AH Linssen, GCM Michels, HR Misier, ARR Schaafsma, HJ Sijbring, P Taverne, RJT Van Kempen, LHJ Van Stralen, R Van Veldhuisen, PJ Veerhoek, MJ Werter, CJPJ Wesdorp, JCL Willems, AR Withagen, AJAM Zwart, PAG Bjornerheim, R Dahle, M Dickstein, K Froland, GS Gullestad, L Gundersen, T Hofsoy, K Hole, TL Johansen, T Mannsverk, J Nesje, P Omland, TM Sjodin, C Smith, P Tjonndal, HA Vikesdal, O Waage, K Jaworska, K Kolodziej, P Kornacewicz-Jach, Z Krzeminska-Pakula, M Kuch, J Piotrowski, JW Piwowarska, W Stogowski, A Wodniecki, J Wrabec, K Ahlstrom, P Ekdahl, S Hemmingson, LO Herlitz, J Holmberg, L Lernfelt, B Nilsson, H Widgren, B Angman, K Erne, P Mohacsi, P Polikar, R Rickenbacher, P Schlapfer, H Batin, P Berkin, KE Callaghan, TS Forfar, J Frenneaux, M Greenbaum, RA Maltz, M Murdoch, D Reynolds, G Stephens, J Struthers, A Swan, J Tildesley, G Abbasi, A Alagona, P Alderman, J Alipour, M Anderson, JL Ansari, Z Ashraf, M Beanblossom, BT Bennett, S Benvenuti, D Berk, MR Bhalla, R Bilazarian, SD Browne, KF Buchter, CM Carlson, R Carlson, CJ Danisa, K Dauber, I DeWood, MA Deedwania, P Dennish, G Denny, DM DiBianco, R Diller, PM Dunlap, M Dowd, K Edmiston, A El Shahawy, M Elkayam, U Farnham, J Fenster, P Friedman, S Heywood, T Galichia, JP Geller, M Ghali, JK Gheorghiade, M Giles, T Gillespe, R Goldberg, G Goldberg, MC Goldscher, DA Gooden, GP Goodman, M Goodman, L Gorwit, J Gottlieb, SS Gradman, A Grech, D Hack, T Hall, JH Hattenhauer, MT Higginbotham, MB Hutchins, S Imburgia, M Iteld, BJ Jackson, B Jafri, S Jauch, W Jennison, S Kahn, BH Kao, W Kaplan, K Karlsberg, R Kennedy, HL Kennedy, JJ Kirkegaard, L Kraus, DH LaBresh, K Lalonde, L Lesser, MF Levites, R Levy, M Lewis, RK Loh, IK Madyoon, H Maislos, F Mann, D Maurice, GL Nisar, A Old, W Pappas, JD Phadke, K Promisloff, S Rashkow, AM Reeves, B Rosen, JH Rotman, M Saleem, T Savran, SV Shah, R Shalev, Y Shanes, JG O'Shaughnessy, M Silverman, B Steingart, RM Swenson, L Syed, K Thadani, U Thorsen, RD Tonkon, MJ Touchon, R Uhl, G Vaska, KJ Wagner, SG Weaver, CJ Weiss, RJ Wickemeyer, WJ Willens, HJ Wilson, JR Wright, R Yellen, L
Citation: A. Hjalmarson et al., Effect of metoprolol CR XL in chronic heart failure: Metoprolol CR XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), LANCET, 353(9169), 1999, pp. 2001-2007
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure
Authors: Cohn, JN Goldstein, SO Greenberg, BH Lorell, BH Bourge, RC Jaski, BE Gottlieb, SO McGrew, F DeMets, DL White, BG
Citation: Jn. Cohn et al., A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure, N ENG J MED, 339(25), 1998, pp. 1810-1816
Risultati: 1-18 |